Michael Wein, MD
Allergy & Immunology · Vero Beach, FLNPI 1336218650
Payments from drug & device makers
Across 41 payments — averaging $317.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$11K
- LEO Pharma Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$159
- AstraZeneca$151
- ADMA Biomanufacturing LLC$150
- Blueprint Medicines Corporation$148
- plus $391 from 7 others
What the payments were for
- Consulting fees$10,20778%
- Travel & lodging$1,49311%
- Food & beverage$1,31810%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 17 | $10,865 |
| LEO Pharma Inc. | 1 | $1,170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $159 |
| AstraZeneca | 2 | $151 |
| ADMA Biomanufacturing LLC | 1 | $150 |
| Blueprint Medicines Corporation | 1 | $148 |
| Novartis | 1 | $140 |
| Pfizer | 5 | $114 |
| Teva Pharmaceuticals USA, Inc. | 1 | $42 |
| GSK | 2 | $32 |
| Sanofi | 1 | $28 |
| Alk-abello, Inc | 1 | $21 |
| Genentech USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Andembry$7,339
How this compares
$13,033 in reported general payments places this provider in the 65th percentile of 204 allergy & immunology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 65 | $349,472 |
| Dupixent SyringeDupilumab | 59 | $222,944 |
| NucalaMepolizumab | 13 | $167,092 |
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 54 | $136,103 |
| XolairOmalizumab | 35 | $95,125 |
| TezspireTezepelumab-Ekko | 22 | $89,619 |
| Breo ElliptaFluticasone/Vilanterol | 61 | $31,786 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $30,914 |
| Ipratropium Bromide | 552 | $13,435 |
| Epinephrine | 56 | $10,788 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $9,235 |
| Arnuity ElliptaFluticasone Furoate | 13 | $4,197 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 21 | $3,357 |
| Pulmicort FlexhalerBudesonide | 14 | $3,314 |
| Wixela InhubFluticasone Propion/Salmeterol | 33 | $2,869 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $10,865 | $349,47265 claims |
| GSKNucala, Breo Ellipta, Trelegy Ellipta, Arnuity Ellipta | $32 | $233,988121 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Cuvitru | $159 | $136,10354 claims |
| AstraZenecaTezspire, Breztri Aerosphere, Pulmicort Flexhaler | $151 | $102,16851 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 204 allergy & immunology providers in Florida.
Other allergy & immunology in Vero Beach
- Jaime LandmanAventura$3.9M
- Ileana RodicioMiami$3.8M
- Jose CarpioMiami$3.6M
- Michael KohenDaytona Beach$3.6M
- Thomas CasaleTampa$1.7M
- Dennis LedfordTampa$1.4M
- Ronald SaffTallahassee$1.2M
- Shahnaz FattehPlantation$1M
- Seong ChoTampa$969K
- Thomas WestbrookPensacola$925K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.